摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

μ-oxo-bis[(5,10,15,20-tetrakis(pentafluorophenyl)porphyrinato)iron(III)] | 81245-20-7

中文名称
——
中文别名
——
英文名称
μ-oxo-bis[(5,10,15,20-tetrakis(pentafluorophenyl)porphyrinato)iron(III)]
英文别名
μ-oxo-bis((5,10,15,20)tetrakispentafluorophenyl)porphinatoiron(II);μ-oxo-(tetrakis(pentafluorophenyl)porphinato)iron(III)2;[[5,10,15,20-tetrakis(pentafluorophenyl)porphinato]iron(III)]O;μ-O(Fe-meso-tetrakis(pentafluorophenyl)porphyrin)2;μ-O(FeTPFPP)2;[FeTPFPP]2O
CAS
81245-20-7
化学式
C88H16F40Fe2N8O
mdl
——
分子量
2072.78
InChiKey
BBESRISORFQDSV-JZUWWCKTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    20.62
  • 重原子数:
    139.0
  • 可旋转键数:
    10.0
  • 环数:
    20.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    78.39
  • 氢给体数:
    0.0
  • 氢受体数:
    9.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • An efficient eco-sustainable oxidative desulfurization process using μ-oxo-bridged Fe(III) complex of meso-tetrakis(pentafluorophenyl)porphyrin
    作者:António Aguiar、Susana Ribeiro、André M.N. Silva、Luís Cunha-Silva、Baltazar de Castro、Ana M.G. Silva、Salete S. Balula
    DOI:10.1016/j.apcata.2014.04.002
    日期:2014.5
    The present work is the first report of using a FeIII dimeric porphyrin as an active and efficient catalyst for the oxidative desulfurization of a multicomponent oil formed by the most refractory sulfur compounds in fuels (dibenzothiophene, DBT, 1-benzothiophene, 1-BT, and 4,6-dimethyldibenzothiophene, 4,6-DMDBT), using the biphasic system model oil/extraction solvent. The binuclear μ-oxodiiron(III)
    本工作是首次使用Fe III二聚卟啉作为活性和高效催化剂对燃料(二苯并噻吩,DBT,1-苯并噻吩,1-BT,和4,6-二甲基二苯并噻吩(4,6-DMDBT),使用双相系统模型油/萃取溶剂。合成了介孔四(五氟苯基)卟啉μ-O(FeTPFPP)2的双核μ-氧二(III)配合物,并通过紫外/可见光谱,质谱和单晶X射线衍射进行了表征。μ-O(FeTPFPP)2在室温下,当残留量的H 2 O 2存在时,当使用乙腈甲醇作为萃取溶剂时,H2O3表现出完全脱。按照1-BT> DBT> 4,6-DMDBT的顺序对每种难处理的化合物评估卟啉的催化效率。出人意料的是,与文献中已报道的其他催化剂相比,卟啉对1-BT的脱表现出显着的催化性能。此外,含有卟啉的萃取相可在连续的脱循环中重复使用。
  • Mechanistic Studies of (Porphinato)Iron-Catalyzed Isobutane Oxidation. Comparative Studies of Three Classes of Electron-Deficient Porphyrin Catalysts
    作者:Kevin T. Moore、István T. Horváth、Michael J. Therien
    DOI:10.1021/ic000284o
    日期:2000.7.24
    We report herein a comprehensive study of (porphinato)iron [PFe]-catalyzed isobutane oxidation in which molecular oxygen is utilized as the sole oxidant; these catalytic reactions were carried out and monitored in both autoclave reactors and sapphire NMR tubes. In situ 19F and 13C NMR experiments, coupled with GC analyses and optical spectra obtained from the autoclave reactions have enabled the identification
    我们在此报告了对(卟啉[PFe]催化的异丁烷氧化的全面研究,其中分子氧被用作唯一的氧化剂。这些催化反应在高压釜反应器和蓝宝石NMR管中进行并监测。原位19F和13C NMR实验,再加上气相色谱分析和从高压釜反应获得的光谱,已经能够鉴定PFe催化的异丁烷氧化过程中存在的主要卟啉类。基于5,10,15,20-四(五氟苯基)卟啉[(C6F5)4PH2],2,3,7,8,12,13,17,18-octabromo-5,10,15的缺电子PFe催化剂研究了20,四(五氟苯基)卟啉[Br8( )4PH2]和5,10,15,20-四(七丙基)卟啉[(C3F7)4PH2]大环。烃氧化产物的性质和分布表明,自氧化反应途径支配了反应动力学,这与自由基链过程一致。对于每个检查的催化体系,显示在80摄氏度的中等O2压力下PFeII种类不稳定。在每种情况下,在观察到任何烃类氧化产物之前,都要先将PFeI
  • 19F NMR Spectra and Structures of Halogenated Porphyrins
    作者:Eva R. Birnbaum、Julia A. Hodge、Mark W. Grinstaff、William P. Schaefer、Lawrence Henling、Jay A. Labinger、John E. Bercaw、Harry B. Gray
    DOI:10.1021/ic00118a010
    日期:1995.7
    Fluorine-19 NMR spectra of a series of halogenated porphyrins have been used to create a spectral library of different types of fluorine splitting patterns for tetrakis(pentafluorophenyl) porphyrins (TFPP) complexed with diamagnetic and paramagnetic metal ions. The paramagnetic shift, line broadening, and fine structure of the resonances from the peripheral pentafluorophenyl rings are dependent on the symmetry and core environment of the porphyrin macrocycles. In combination with crystal structure data, F-19 NMR helps define the behavior of halogenated porphyrins in solution. Six new crystal structures for TFPP and octahalo-TFPP derivatives are reported: H2TFPP in rhombohedral space group R (3) over bar, a = 20.327(4) Angstrom, c = 24.368(5) Angstrom, V = 8720(3) Angstrom(3), Z = 9; ZnTFPP in monoclinic space group P2(1)/c, a = 12.653(4) Angstrom, b = 11.883(5) Angstrom, c = 15.261(2) Angstrom, beta = 103.87(2)degrees, V = 2227.6(13) Angstrom(3), Z = 2; CuTFPP in rhombohedral space group R (3) over bar, a = 20.358(5), c = 24.347(6) Angstrom, V = 8739(4) Angstrom(3), Z = 9; H2TFPPCl8 in triclinic space group P (1) over bar, a = 11.066(1) Angstrom, b = 14.641(3) Angstrom, c = 14.678(2) Angstrom, alpha = 88.97(1), beta = 76.05(1)degrees, gamma = 71.29(1)degrees, V = 2181.4(6) Angstrom(3), Z = 2; ZnTFPPCl8 in tetragonal space group P (4) over bar 2(1)c, a = 19.502(20), c = 10.916(8) Angstrom, V = 4152(6) Angstrom(3), Z = 2; H2TFPPBr8 in monoclinic space group C2, a = 27.634(6) Angstrom, b = 6.926(2) Angstrom, c = 14.844(3) Angstrom, beta = 109.64(2)degrees, V = 2675.8(11) Angstrom(3), Z = 2.
  • Characterization of a<i>μ</i>-oxo-bridged diiron porphyrin by ESI-LTQ-Orbitrap-MS
    作者:André M. N. Silva、António Aguiar、Salete S. Balula、Ana M. G. Silva、Maria Rangel
    DOI:10.1002/jms.3405
    日期:2014.8
  • Shin, Koo; Yu, Byung-Soo; Goff, Harold M., Inorganic Chemistry, 1990, vol. 29, # 4, p. 889 - 890
    作者:Shin, Koo、Yu, Byung-Soo、Goff, Harold M.
    DOI:——
    日期:——
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)